Intrinsiqs

Is Theravance Biopharma Inc overvalued?

Theravance Biopharma Inc (TBPH) — key valuation metrics and fundamentals.

No verdict
Price
$16.97
Fair value
Current P/E
Normal P/E
Market cap
$879.5M
Dividend yield
0.0%
Return on equity
16.7%
Sector
Healthcare

See the full interactive analysis →

Fair value compares TBPH's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.